Richter And Evestra Enter Into Collaboration Agreement
News Mar 02, 2015
Gedeon Richter Plc. and Evestra Inc. have signed a collaboration agreement in which Richter is providing a USD $5-million convertible loan to Evestra. The funds will empower Evestra to accelerate the development of its innovative women’s health product pipeline into clinical stages.
Under the terms of the agreement, after three years Richter has an option to decide whether the loan is to be reimbursed, including earned interest, or converted into an equity stake in Evestra.
Old age is the greatest risk factor for many diseases, including Alzheimer's disease (AD) and cancer. Geroprotectors are a recently identified class of anti-aging compounds. New research has now identified a unique subclass of these compounds, dubbed geroneuroprotectors (GNPs), which are AD drug candidates and slow the aging process in mice.READ MORE